The alleviating effect of QPE on NAFLD required AMPK activation to hamper the maturation of SREBP-1c and consequently decrease the lipid accumulation derived from DNL. The gene discussed is SREBF1; the disease is metabolic dysfunction-associated steatotic liver disease.